NZSE:RYMHealthcare
Ryman Healthcare (NZSE:RYM) Following FY2027 Guidance Is Its Valuation Story Back In Focus
Ryman Healthcare (NZSE:RYM) is back in focus after issuing fiscal 2027 sales guidance and confirming build plans for 157 to 168 units and beds, alongside first quarter sales data for occupation right agreements.
See our latest analysis for Ryman Healthcare.
At a share price of NZ$2.18, Ryman Healthcare has seen its 90 day share price return of 9% contrast with a year to date share price decline of 26.35%, while the 5 year total shareholder return is down 80.22%. This points to longer term...